Mutations engineered into the mouse Trp53 gene locus are valuable tools to delineate in vivo tumor suppressor functions in tumorigenesis and cancer therapy (Bieging et al, 2014; Mello & Attardi, 2018). This evidence concerns the gene TP53 and neoplasm.